CD133-negative glioma cells transplanted into brain mice expressed high levels of HIF1/2α and concomitant expression of CD133, which indicate the strong effect of the tumoral microenvironment on CD133 expression levels and cell phenotype [136]. The gene discussed is PROM1; the disease is glioma.